Evidence map›Paper›PMID 31671811›Full record

ArticleMolecules (Basel, Switzerland)2019

Antimalarial Drugs Enhance the Cytotoxicity of 5-Aminolevulinic Acid-Based Photodynamic Therapy against the Mammary Tumor Cells of Mice In Vitro.

Tomohiro Osaki, Kiwamu Takahashi, Masahiro Ishizuka, Tohru Tanaka, Yoshiharu Okamoto

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tomohiro OsakiJoint Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, Tottori 680-8553, Japan. tosaki@muses.tottori-u.ac.jp.ORCID 0000-0002-2689-9435
Kiwamu TakahashiSBI Pharmaceuticals Co., Ltd., Tokyo 106-6020, Japan. kiwtakah@sbigroup.co.jp.
Masahiro IshizukaSBI Pharmaceuticals Co., Ltd., Tokyo 106-6020, Japan. mishizuk@sbigroup.co.jp.
Tohru TanakaSBI Pharmaceuticals Co., Ltd., Tokyo 106-6020, Japan. tortanaka@sbigroup.co.jp.
Yoshiharu OkamotoJoint Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, Tottori 680-8553, Japan. yokamoto@muses.tottori-u.ac.jp.
SBI Pharmaceuticals (Japan) · JPTottori University · JP

Funding

SBI Pharmaceuticals Co., Ltd. (Tokyo, Japan). There is no number.
6 · The paper itself

Abstract

Artemisinin and its derivatives, including artesunate (ART) and artemether (ARM), exert anticancer effects in the micromolar range in drug and radiation-resistant cell lines. Artemisinin has been reported to sensitize cervical cancer cells to radiotherapy. In the present study, we determined whether ART and ARM could enhance the cytotoxicity of 5-aminolevulinic acid (5-ALA)-based photodynamic therapy (PDT) against the mammary tumor cells of mice. The corrected PpIX fluorescence intensities in the control, 5-ALA, 5-ALA + ART, and 5-ALA + ARM groups were 3.385 ± 3.730, 165.7 ± 33.45, 139.0 ± 52.77, and 165.4 ± 51.10 a.u., respectively. At light doses of 3 and 5 J/cm

Indexed as

PhotochemotherapyAcetylcysteineAminolevulinic AcidAnimalsAntimalarialsAntioxidantsApoptosisCell Line, TumorCell ShapeFemaleFluorescenceMammary Neoplasms, AnimalMiceProtoporphyrinsReactive Oxygen SpeciesAcetylcysteineAminolevulinic AcidAntimalarialsAntioxidantsprotoporphyrin IXProtoporphyrinsReactive Oxygen Species5-aminolevulinic acidantimalarialartemetherartemisininartesunatecytotoxicityphotodynamic therapyreactive oxygen species

Identifiers

PMID31671811
PMCPMC6866132
OpenAlexW2982330216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.